| Product Code: ETC319648 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The colistin market size in Indonesia was valued at USD 0.30 million in 2025 and is anticipated to expand at a CAGR of 4.1% over the forecast period. Growing awareness regarding animal health along with improved financial conditions are some of major factors that augmenting product demand in this country. Additionally, high prevalence rate of transboundary animal diseases such as foot & mouth disease (FMD) has led farmers? shift toward preventive measures including vaccination programs which is further boosting colistin use among livestock animals such as poultry & cattle farms across this region over last few years thus propelling regional market growth during the estimated peroid.
The Indonesia Colistin market growth is influenced by its use as an antibiotic for treating bacterial infections, particularly in healthcare settings. The emergence of antibiotic-resistant bacteria has underscored the importance of effective antibiotics like colistin. Market dynamics include antibiotic stewardship, healthcare policies, and infectious disease trends.
Challenges involve concerns about antibiotic resistance, regulatory complexities, and potential adverse effects. Implementing responsible use guidelines and fostering research into alternative solutions are crucial to overcoming these challenges.
The Indonesia Colistin market experienced shifts in antibiotic use and prescription patterns during the pandemic. The focus on treating COVID-19 patients and concerns about antimicrobial resistance impacted the market dynamics.
The colistin market relates to antibiotic usage in animal husbandry and veterinary medicine. Companies like PT. Sanbe Farma and PT. Kimia Farma are major pharmaceutical players in Indonesia that could be involved in this market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Colistin Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Colistin Market - Industry Life Cycle |
3.4 Indonesia Colistin Market - Porter's Five Forces |
3.5 Indonesia Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Indonesia Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Indonesia Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Indonesia |
4.2.2 Growing awareness about the effectiveness of colistin in treating multidrug-resistant infections |
4.2.3 Rising investments in healthcare infrastructure and facilities in Indonesia |
4.3 Market Restraints |
4.3.1 Stringent regulations regarding the use of colistin due to its potential contribution to antimicrobial resistance |
4.3.2 High cost of colistin compared to alternative antibiotics |
4.3.3 Concerns about the side effects and toxicity associated with colistin usage |
5 Indonesia Colistin Market Trends |
6 Indonesia Colistin Market, By Types |
6.1 Indonesia Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Colistin Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Indonesia Colistin Market Revenues & Volume, By API, 2021-2031F |
6.1.4 Indonesia Colistin Market Revenues & Volume, By Premix, 2021-2031F |
6.1.5 Indonesia Colistin Market Revenues & Volume, By Others, 2021-2031F |
6.2 Indonesia Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Colistin Market Revenues & Volume, By Pig, 2021-2031F |
6.2.3 Indonesia Colistin Market Revenues & Volume, By Chicken, 2021-2031F |
6.2.4 Indonesia Colistin Market Revenues & Volume, By Other, 2021-2031F |
7 Indonesia Colistin Market Import-Export Trade Statistics |
7.1 Indonesia Colistin Market Export to Major Countries |
7.2 Indonesia Colistin Market Imports from Major Countries |
8 Indonesia Colistin Market Key Performance Indicators |
8.1 Number of hospitals and healthcare facilities using colistin in Indonesia |
8.2 Percentage increase in prescriptions of colistin over time |
8.3 Rate of adoption of colistin in treating multidrug-resistant infections |
8.4 Number of research studies or clinical trials conducted on colistin in Indonesia |
8.5 Patient outcomes and recovery rates associated with colistin treatment |
9 Indonesia Colistin Market - Opportunity Assessment |
9.1 Indonesia Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Indonesia Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Indonesia Colistin Market - Competitive Landscape |
10.1 Indonesia Colistin Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |